Role of Radiation Therapy in Pediatric Cancer

Hematology/Oncology Clinics of North America

Volumn 20, Issue 2, 2006, Pages 455-470

  Gibbs, Iris C ^a   Tuamokumo, Nimi ^b   Yock, Torunn I ^b  

^a STANFORD CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; VINCRISTINE;

BONE MARROW TRANSPLANTATION; BRAIN TUMOR; CANCER; CANCER SURVIVAL; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL FEATURE; EWING SARCOMA; HISTOLOGY; HODGKIN DISEASE; HUMAN; LEUKEMIA; LYMPHATIC LEUKEMIA; LYMPHOMA; NEPHROBLASTOMA; NEUROBLASTOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; RHABDOMYOSARCOMA; SARCOMA; ACUTE LYMPHOCYTIC LEUKEMIA; ADOLESCENT; CHILD; INCIDENCE; NEOPLASM; UNITED STATES;

ADOLESCENT; BRAIN NEOPLASMS; CHILD; HODGKIN DISEASE; HUMANS; INCIDENCE; LEUKEMIA, LYMPHOCYTIC, ACUTE; LYMPHOMA, NON-HODGKIN; NEOPLASMS; SARCOMA; UNITED STATES;

EID: 33746883580     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.01.015     Document Type: Review

References (78)

1. National Program for Cancer Registries. 2001 Appendix D3. Childhood case counts by ICCC group (2001). Available at: http://apps.nccd.cdc.gov/uscs/Table.aspx?Group=TableICCC& Year=2002&Display=n Accessed October 1, 2005
2. Ries L.A.G. Childhood cancer mortality. In: Ries L.A.G., Smith M.A., Gurney J.G., et al. (Eds). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 (1999), National Cancer Institute, SEER Program, Bethesda (MD) 165-169 NIH Pub. No. 99-4649
3. Smith M.A., and Gloeckler Ries L.A. Childhood cancer: incidence, survival, and mortality. In: Pizzo P.A., and Poplack D.G. (Eds). Principles and practice of pediatric oncology. 4th edition (2002), Lippincott Williams & Wilkins, Philadelphia 1-12
4. Jemal A., Tiwari R.C., Murray T., et al. Cancer statistics, 2004. CA Cancer J Clin 54 1 (2004) 8-29
5. Ross J.A., and Olshan A.F. Pediatric cancer in the United States: the Children's Oncology Group Epidemiology Research Program. Cancer Epidemiol Biomarkers Prev 13 10 (2004) 1552-1554
6. Schwartz C.L. Long-term survivors of childhood cancer: the late effects of therapy. Oncologist 4 1 (1999) 45-54
7. Jemal A., Murray T., Samuels A., et al. Cancer statistics, 2003. CA Cancer J Clin 53 1 (2003) 5-26
8. Gurney J.G., Davis S., Severson R.K., et al. Trends in cancer incidence among children in the US. Cancer 78 3 (1996) 532-541
9. Swensen A.R., Ross J.A., Severson R.K., et al. The age peak in childhood acute lymphoblastic leukemia: exploring the potential relationship with socioeconomic status. Cancer 79 10 (1997) 2045-2051
10. Pui C.H., Relling M.V., and Downing J.R. Acute lymphoblastic leukemia. N Engl J Med 350 15 (2004) 1535-1548
11. Evans A.E., Gilbert E.S., and Zandstra R. The increasing incidence of central nervous system leukemia in children (Children's Cancer Study Group A). Cancer 26 2 (1970) 404-409
12. Paolucci G., Vecchi V., Favre C., et al. Treatment of childhood acute lymphoblastic leukemia: long-term results of the AIEOP-ALL 87 study. Haematologica 86 5 (2001) 478-484
13. Hustu H.O., and Aur R.J. Extramedullary leukaemia. Clin Haematol 7 2 (1978) 313-337
14. Hertzberg H., Huk W.J., Ueberall M.A., et al. CNS late effects after ALL therapy in childhood. Part I. Neuroradiological findings in long-term survivors of childhood ALL: an evaluation of the interferences between morphology and neuropsychological performance. The German Late Effects Working Group. Med Pediatr Oncol 28 6 (1997) 387-400
15. Schrappe M., Reiter A., Ludwig W.D., et al. Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90. German-Austrian-Swiss ALL-BFM Study Group. Blood 95 11 (2000) 3310-3322
16. Waber D.P., Shapiro B.L., Carpentieri S.C., et al. Excellent therapeutic efficacy and minimal late neurotoxicity in children treated with 18 grays of cranial radiation therapy for high-risk acute lymphoblastic leukemia: a 7-year follow-up study of the Dana-Farber Cancer Institute Consortium Protocol 87-01. Cancer 92 1 (2001) 15-22
17. Schrappe M., Reiter A., Zimmermann M., et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 14 12 (2000) 2205-2222
18. Schrappe M., Camitta B., Pui C.H., et al. Long-term results of large prospective trials in childhood acute lymphoblastic leukemia. Leukemia 14 12 (2000) 2193-2194
19. Percy C.L., Smith M.A., Linet M., et al. Lymphomas and reticuloendothelial neoplasms. In: Ries L.A.G., Smith M.A., Gurney J.G., et al. (Eds). Cancer incidence and survival among children and adolescents: United States SEER Program 1975-1995 (1999), National Cancer Institute, SEER Program, Bethesda (MD) 35-50 NIH Pub. No. 99-4649
20. Tarbell N.J., and Weinstein H.J. Non-Hodgkin's lymphoma. In: Halperin E.C., Constine L.S., Tarbell N.J., et al. (Eds). Pediatric radiation oncology. 4th edition (2005), Lippincott Williams & Wilkins, Philadelphia 261-270
21. Hudson M.M., and Constine L.S. Hodgkin's disease. In: Halperin E.C., Constine L.S., Tarbell N.J., et al. (Eds). Pediatric radiation oncology (2005), Lippincott Williams & Wilkins, Philadelphia 223-259
22. Hutchinson R.J., Fryer C.J., Davis P.C., et al. MOPP or radiation in addition to ABVD in the treatment of pathologically staged advanced Hodgkin's disease in children: results of the Children's Cancer Group Phase III Trial. J Clin Oncol 16 3 (1998) 897-906
23. Nachman J.B., Sposto R., Herzog P., et al. Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy. J Clin Oncol 20 18 (2002) 3765-3771
24. Weiner M.A., Leventhal B., Brecher M.L., et al. Randomized study of intensive MOPP-ABVD with or without low-dose total-nodal radiation therapy in the treatment of stages IIB, IIIA2, IIIB, and IV Hodgkin's disease in pediatric patients: a Pediatric Oncology Group study. J Clin Oncol 15 8 (1997) 2769-2779
25. Lashford L.S., Thiesse P., Jouvet A., et al. Temozolomide in malignant gliomas of childhood: a United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup Study. J Clin Oncol 20 24 (2002) 4684-4691
26. Stupp R., Mason W.P., van den Bent M.J., et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352 10 (2005) 987-996
27. Merchant T.E., Kiehna E.N., Li C., et al. Radiation dosimetry predicts IQ after conformal radiation therapy in pediatric patients with localized ependymoma. Int J Radiat Oncol Biol Phys 63 5 (2005) 1546-1554 Epub 2005 Aug 22
28. Merchant T.E., Mulhern R.K., Krasin M.J., et al. Preliminary results from a phase II trial of conformal radiation therapy and evaluation of radiation-related CNS effects for pediatric patients with localized ependymoma. J Clin Oncol 22 15 (2004) 3156-3162
29. Packer R.J., and Reddy A. New treatments in pediatric brain tumors. Curr Treat Options Neurol 6 5 (2004) 377-389
30. Bloom H.J., Wallace E.N., and Henk J.M. The treatment and prognosis of medulloblastoma in children: a study of 82 verified cases. Am J Roentgenol Radium Ther Nucl Med 105 1 (1969) 43-62
31. Fukunaga-Johnson N., Lee J.H., Sandler H.M., et al. Patterns of failure following treatment for medulloblastoma: is it necessary to treat the entire posterior fossa?. Int J Radiat Oncol Biol Phys 42 1 (1998) 143-146
32. Wolden S.L., Dunkel I.J., Souweidane M.M., et al. Patterns of failure using a conformal radiation therapy tumor bed boost for medulloblastoma. J Clin Oncol 21 16 (2003) 3079-3083
33. Matthay K.K. Neuroblastoma: biology and therapy. Oncology (Williston Park) 11 12 (1997) 1857-1866 [discussion: 1869-72, 1875]
34. Angstman K.B., Miser J.S., and Franz III W.B. Neuroblastoma. Am Fam Physician 41 1 (1990) 238-244
35. Stephenson S.R., Cook B.A., Mease A.D., et al. The prognostic significance of age and pattern of metastases in stage IV-S neuroblastoma. Cancer 58 2 (1986) 372-375
36. Look A.T., Hayes F.A., Shuster J.J., et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 9 4 (1991) 581-591
37. Evans A.E., D'Angio G.J., Propert K., et al. Prognostic factor in neuroblastoma. Cancer 59 11 (1987) 1853-1859
38. Nickerson H.J., Matthay K.K., Seeger R.C., et al. Favorable biology and outcome of stage IV-S neuroblastoma with supportive care or minimal therapy: a Children's Cancer Group study. J Clin Oncol 18 3 (2000) 477-486
39. Strother D., van Hoff J., Rao P.V., et al. Event-free survival of children with biologically favourable neuroblastoma based on the degree of initial tumour resection: results from the Pediatric Oncology Group. Eur J Cancer 33 12 (1997) 2121-2125
40. Hsu L.L., Evans A.E., and D'Angio G.J. Hepatomegaly in neuroblastoma stage 4s: criteria for treatment of the vulnerable neonate. Med Pediatr Oncol 27 6 (1996) 521-528
41. Castleberry R.P., Kun L.E., Shuster J.J., et al. Radiotherapy improves the outlook for patients older than 1 year with Pediatric Oncology Group stage C neuroblastoma. J Clin Oncol 9 5 (1991) 789-795
42. de Bernardi B., Rogers D., Carli M., et al. Localized neuroblastoma: surgical and pathologic staging. Cancer 60 5 (1987) 1066-1072
43. Matthay K.K., Villablanca J.G., Seeger R.C., et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid: Children's Cancer Group. N Engl J Med 341 16 (1999) 1165-1173
44. Haas-Kogan D.A., Swift P.S., Selch M., et al. Impact of radiotherapy for high-risk neuroblastoma: a Children's Cancer Group study. Int J Radiat Oncol Biol Phys 56 1 (2003) 28-39
45. Marcus K.J., Shamberger R., Litman H., et al. Primary tumor control in patients with stage 3/4 unfavorable neuroblastoma treated with tandem double autologous stem cell transplants. J Pediatr Hematol Oncol 25 12 (2003) 934-940
46. Morgenstern B.Z., Krivoshik A.P., Rodriguez V., et al. Wilms' tumor and neuroblastoma. Acta Paediatr Suppl 93 445 (2004) 78-84 [discussion: 84-75]
47. Kalapurakal J.A., Dome J.S., Perlman E.J., et al. Management of Wilms' tumour: current practice and future goals. Lancet Oncol 5 1 (2004) 37-46
48. Beckwith J.B. Wilms' tumor and other renal tumors of childhood: a selective review from the National Wilms' Tumor Study Pathology Center. Hum Pathol 14 6 (1983) 481-492
49. Grundy P., and Coppes M. An overview of the clinical and molecular genetics of Wilms' tumor. Med Pediatr Oncol 27 5 (1996) 394-397
50. Grundy P., Telzerow P., Moksness J., et al. Clinicopathologic correlates of loss of heterozygosity in Wilms' tumor: a preliminary analysis. Med Pediatr Oncol 27 5 (1996) 429-433
51. Kalapurakal J.A., Li S.M., Breslow N.E., et al. Influence of radiation therapy delay on abdominal tumor recurrence in patients with favorable histology Wilms' tumor treated on NWTS-3 and NWTS-4: a report from the National Wilms' Tumor Study Group. Int J Radiat Oncol Biol Phys 57 2 (2003) 495-499
52. Shamberger R.C., Guthrie K.A., Ritchey M.L., et al. Surgery-related factors and local recurrence of Wilms tumor in National Wilms Tumor Study 4. Ann Surg 229 2 (1999) 292-297
53. Thomas P.R., Tefft M., Compaan P.J., et al. Results of two radiation therapy randomizations in the third National Wilms' Tumor Study. Cancer 68 8 (1991) 1703-1707
54. Paulino A.C., Wen B.C., Brown C.K., et al. Late effects in children treated with radiation therapy for Wilms' tumor. Int J Radiat Oncol Biol Phys 46 5 (2000) 1239-1246
55. Egeler R.M., Wolff J.E., Anderson R.A., et al. Long-term complications and post-treatment follow-up of patients with Wilms' tumor. Semin Urol Oncol 17 1 (1999) 55-61
56. Breslow N.E., Takashima J.R., Whitton J.A., et al. Second malignant neoplasms following treatment for Wilm's tumor: a report from the National Wilms' Tumor Study Group. J Clin Oncol 13 8 (1995) 1851-1859
57. Denny C.T. Ewing's sarcoma: a clinical enigma coming into focus. J Pediatr Hematol Oncol 20 5 (1998) 421-425
58. Widhe B., and Widhe T. Initial symptoms and clinical features in osteosarcoma and Ewing sarcoma. J Bone Joint Surg Am 82 5 (2000) 667-674
59. Cotterill S.J., Ahrens S., Paulussen M., et al. Prognostic factors in Ewing's tumor of bone: analysis of 975 patients from the European Intergroup Cooperative Ewing's Sarcoma Study Group. J Clin Oncol 18 17 (2000) 3108-3114
60. Bacci G., Ferrari S., Bertoni F., et al. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: analysis of 359 patients at the Istituto Ortopedico Rizzoli. J Clin Oncol 18 1 (2000) 4-11
61. Horowitz M.E., Neff J.R., and Kun L.E. Ewing's sarcoma: radiotherapy versus surgery for local control. Pediatr Clin North Am 38 2 (1991) 365-380
62. Merchant T.E., Kushner B.H., Sheldon J.M., et al. Effect of low-dose radiation therapy when combined with surgical resection for Ewing sarcoma. Med Pediatr Oncol 33 2 (1999) 65-70
63. Spunt S.L., McCarville M.B., Kun L.E., et al. Selective use of whole-lung irradiation for patients with Ewing sarcoma family tumors and pulmonary metastases at the time of diagnosis. J Pediatr Hematol Oncol 23 2 (2001) 93-98
64. Whelan J.S., Burcombe R.J., Janinis J., et al. A systematic review of the role of pulmonary irradiation in the management of primary bone tumours. Ann Oncol 13 1 (2002) 23-30
65. Pinkerton C.R., Bataillard A., Guillo S., et al. Treatment strategies for metastatic Ewing's sarcoma. Eur J Cancer 37 11 (2001) 1338-1344
66. Paulussen M., Ahrens S., Burdach S., et al. Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9 3 (1998) 275-281
67. Fuchs B., Valenzuela R.G., Inwards C., et al. Complications in long-term survivors of Ewing sarcoma. Cancer 98 12 (2003) 2687-2692
68. Dunst J., Ahrens S., Paulussen M., et al. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies. Int J Radiat Oncol Biol Phys 42 2 (1998) 379-384
69. Punyko J.A., Mertens A.C., Baker K.S., et al. Long-term survival probabilities for childhood rhabdomyosarcoma: a population-based evaluation. Cancer 103 7 (2005) 1475-1483
70. Young Jr. J.L., Ries L.G., Silverberg E., et al. Cancer incidence, survival, and mortality for children younger than age 15 years. Cancer 58 2 Suppl (1986) 598-602
71. Sung L., Anderson J.R., Donaldson S.S., et al. Late events occurring five years or more after successful therapy for childhood rhabdomyosarcoma: a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Eur J Cancer 40 12 (2004) 1878-1885
72. Crist W., Gehan E.A., Ragab A.H., et al. The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13 3 (1995) 610-630
73. Maurer H.M., Gehan E.A., Beltangady M., et al. The Intergroup Rhabdomyosarcoma Study-II. Cancer 71 5 (1993) 1904-1922
74. Turc-Carel C., Lizard-Nacol S., Justrabo E., et al. Consistent chromosomal translocation in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 19 3-4 (1986) 361-362
75. Kelly K.M., Womer R.B., Sorensen P.H., et al. Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15 5 (1997) 1831-1836
76. Dagher R., and Helman L. Rhabdomyosarcoma: an overview. Oncologist 4 1 (1999) 34-44
77. Raney R.B., Anderson J.R., Barr F.G., et al. Rhabdomyosarcoma and undifferentiated sarcoma in the first two decades of life: a selective review of intergroup rhabdomyosarcoma study group experience and rationale for Intergroup Rhabdomyosarcoma Study V. J Pediatr Hematol Oncol 23 4 (2001) 215-220
78. Crist W.M., Anderson J.R., Meza J.L., et al. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol 19 12 (2001) 3091-3102